This is Ray Nash, Corporate Finance Leader for Novanta Inc. With me on today’s call is our Chair and Chief Executive Officer, Matthijs Glastra, and our Chief Financial Officer, Robert J. Buckley.
Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...
Nebius delivered $227.7 million in Q4 revenue, up 547% year-over-year, with implied gross margins near 70%. Click here to ...
On a sunny Sunday afternoon, residents, dignitaries and Scientologists gathered near the sparkling center of the city for a celebration filled with bomba and plena music. The passion soared as dancers ...
Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results